MagVenture

MagVenture is a Danish medical device company that specializes in non-invasive Transcranial Magnetic Stimulation (TMS) technology. With over 30 years of experience, the company designs, develops, and produces TMS systems in Denmark, ensuring compliance with international standards such as ISO 13485:2012. Their products are approved for use in multiple countries, including the USA, Europe, Canada, China, and Japan. The company offers advanced TMS stimulators and coils for both clinical treatment and research applications. Their technology is primarily used in psychiatry to treat major depressive disorder, particularly in patients who have not responded to traditional medications. MagVenture also collaborates with neuroscientists globally to support research in brain function and neuroplasticity. Notably, they were the first TMS company to receive FDA clearance for Express TMS®, which significantly reduces treatment time, enhancing patient convenience. With a global presence, MagVenture serves psychiatrists, neurologists, researchers, and clinic administrators, providing high-quality solutions for mental health care and brain science.

• Employees 140
• Founded 1992
• Annual Revenue $10000000